News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
200,759 Results
Type
Article (8497)
Company Profile (13)
Press Release (192249)
Multimedia
Podcasts (6)
Webinars (6)
Section
Business (78302)
Career Advice (453)
Deals (11408)
Drug Delivery (16)
Drug Development (22727)
Employer Resources (52)
FDA (4338)
Job Trends (4226)
News (116037)
Policy (8438)
Tag
Academia (700)
Adcomms (11)
Allergies (25)
Alliances (13329)
ALS (18)
Alzheimer's disease (432)
Antibody-drug conjugate (ADC) (30)
Approvals (4385)
Artificial intelligence (70)
Autoimmune disease (1)
Automation (3)
Bankruptcy (73)
Best Places to Work (3583)
BIOSECURE Act (3)
Biosimilars (19)
Biotechnology (9)
Bladder cancer (17)
Brain cancer (7)
Breast cancer (64)
Cancer (649)
Cardiovascular disease (34)
Career advice (382)
Career pathing (10)
CAR-T (30)
Cell therapy (103)
Cervical cancer (7)
Clinical research (19099)
Collaboration (242)
Compensation (31)
Complete response letters (3)
COVID-19 (565)
CRISPR (15)
C-suite (93)
Cystic fibrosis (21)
Data (690)
Decentralized trials (1)
Denatured (3)
Depression (5)
Diabetes (78)
Diagnostics (2026)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (29)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (15)
Earnings (44715)
Editorial (7)
Employer branding (8)
Employer resources (47)
Events (28079)
Executive appointments (222)
FDA (4720)
Frontotemporal dementia (3)
Funding (142)
Gene editing (27)
Generative AI (8)
Gene therapy (72)
GLP-1 (123)
Government (982)
Grass and pollen (1)
Guidances (95)
Healthcare (5362)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (23)
Indications (12)
Infectious disease (610)
Inflammatory bowel disease (35)
Influenza (14)
Intellectual property (28)
Interviews (67)
IPO (5762)
IRA (2)
Job creations (831)
Job search strategy (350)
Kidney cancer (7)
Labor market (2)
Layoffs (83)
Leadership (5)
Legal (1596)
Liver cancer (20)
Lung cancer (113)
Lymphoma (50)
Machine learning (1)
Management (19)
Manufacturing (71)
MASH (6)
Medical device (4321)
Medtech (4321)
Mergers & acquisitions (5772)
Metabolic disorders (142)
Multiple sclerosis (24)
Neurodegenerative disease (20)
Neuropsychiatric disorders (4)
Neuroscience (569)
NextGen: Class of 2025 (1621)
Non-profit (1224)
Now hiring (2)
Obesity (69)
Opinion (41)
Ovarian cancer (25)
Pain (14)
Pancreatic cancer (20)
Parkinson's disease (58)
Partnered (2)
Patents (49)
Patient recruitment (28)
Peanut (17)
People (19016)
Pharmaceutical (8)
Phase I (5110)
Phase II (8090)
Phase III (7247)
Pipeline (566)
Policy (13)
Postmarket research (817)
Preclinical (2091)
Press Release (12)
Prostate cancer (28)
Psychedelics (2)
Radiopharmaceuticals (84)
Rare diseases (77)
Real estate (1512)
Recruiting (19)
Regulatory (6418)
Reports (8)
Research institute (659)
Resumes & cover letters (63)
Rett syndrome (1)
RSV (13)
Schizophrenia (24)
Series A (27)
Series B (19)
Service/supplier (1)
Sickle cell disease (11)
Spinal muscular atrophy (28)
Sponsored (7)
Startups (786)
Stomach cancer (4)
Supply chain (14)
Tariffs (7)
The Weekly (3)
Vaccines (161)
Venture capitalists (6)
Weight loss (32)
Women's health (5)
Worklife (5)
Date
Today (60)
Last 7 days (325)
Last 30 days (991)
Last 365 days (8901)
2025 (3227)
2024 (9893)
2023 (11877)
2022 (15696)
2021 (16962)
2020 (16256)
2019 (13921)
2018 (10665)
2017 (10914)
2016 (9898)
2015 (12215)
2014 (8658)
2013 (6708)
2012 (7350)
2011 (7880)
2010 (6914)
Location
Africa (256)
Alabama (6)
Arizona (35)
Arkansas (1)
Asia (14805)
Australia (2644)
California (1580)
Canada (617)
China (209)
Colorado (68)
Connecticut (50)
Delaware (46)
Europe (32424)
Florida (272)
Georgia (52)
Idaho (23)
Illinois (136)
India (8)
Indiana (99)
Iowa (1)
Japan (87)
Kansas (24)
Kentucky (6)
Louisiana (7)
Maine (40)
Maryland (202)
Massachusetts (1097)
Michigan (76)
Minnesota (114)
Missouri (23)
Montana (12)
Nebraska (6)
Nevada (25)
New Hampshire (24)
New Jersey (587)
New Mexico (5)
New York (429)
North Carolina (302)
North Dakota (2)
Northern California (667)
Ohio (58)
Oklahoma (3)
Oregon (4)
Pennsylvania (383)
Puerto Rico (4)
Rhode Island (5)
South America (442)
South Carolina (11)
Southern California (679)
Tennessee (19)
Texas (192)
United States (6123)
Utah (59)
Virginia (22)
Washington D.C. (12)
Washington State (153)
West Virginia (1)
Wisconsin (18)
200,759 Results for "eps international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025
January 30, 2025
·
3 min read
Press Releases
West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend
April 24, 2025
·
13 min read
Press Releases
Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI
May 5, 2025
·
13 min read
Press Releases
QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook
April 7, 2025
·
5 min read
Press Releases
Eupraxia Pharmaceuticals to Host Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE) on May 9, 2025
May 8, 2025
·
9 min read
Press Releases
Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance
March 4, 2025
·
4 min read
Press Releases
Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update
April 28, 2025
·
9 min read
Press Releases
Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors
January 30, 2025
·
3 min read
Press Releases
Ono Pharma Announces an Oral Presentation on Phase 2 Data for Tirabrutinib and a Poster Session on ONO-4578 (EP4 Antagonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting
April 23, 2025
·
2 min read
Press Releases
Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting
March 25, 2025
·
5 min read
1 of 20,076
Next
